10 dernières publications

Chargement de la page

 

 

Documents en texte intégral

30

Notices

25

 

Publications ouvertes

69 %

 

Mots clés

MOG Myelitis Treatment response Choroid plexus Blood–brain barrier Multiple sclerosis MOG antibodies Autoantibodies Collapsing response mediator protein Neuroinflammation Circadian clock Lateral diffusion CRMP5 Neurite outgrowth Breastfeeding Cytokines Influx constant MOGAD Estradiol Immune checkpoint inhibitors Anti-GFAP encephalomyelitis Bone Clinically isolated syndrome CIS Relapses Toll-like receptor Optic neuritis Blood–CSF barrier LAT1 Microglia Aquaporin-4-IgG AQP4-IgG Adult neurogenesis CP Neuroscience CP Molecular biology Glia B cells Neuromyelitis optica Database Neurological immune-related adverse events Aquaporin-4 antibodies Demyelination Biobank Longitudinally extensive transverse myelitis Cancer immunotherapy ERRα Neuraxial analgesia MOG-IgG associated disorders MOGAD COVID-19 Immunosuppressant Registry Neural antibodies GABA Encephalitis Meninges GSK-3β Embryo Bright Claudin Aquaporin-4 Blood-brain barrier Innate immune system Adverse events Cerebrospinal fluid Jaundice Endocannabinoid system Animal model Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Drosophila MRI Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation Disease-modifying treatments NMOSD Prognosis Aquaporin-4 antibody Connexins Gunn Hippocampus Biomarkers Cilia Ependymal cell Multiple sclerosis MS Cancer Neuromyelitis optica spectrum disorder T follicular helper cells T follicular regulatory cells B cells rituximab Post-partum Astrocyte Cannabinoid receptor type 2 Microenvironment Neuromyelitis optica spectrum disorder Glutamate Myelin oligodendrocyte glycoprotein Pregnancy Children Amino acid Autoimmune diseases Blood brain barrier Area postrema syndrome Blood-brain barriers Autoimmune encephalitis Central nervous system Rituximab CD14

 

Collaborations